Jeff Bone

🌍 Thrilled to share that Caresyntax has taken the World Economic Forum's Global Health Equity Zero Gaps pledge, further aligning with our mission to create a world with equal access to healthcare. This pledge focuses on closing the gap in healthcare access, affordability, and quality-key pillars of the WEF’s Sustainable Development Goals. Since joining the WEF’s Unicorn and Health Platform, we've enhanced our AI-driven surgical platform and expanded our ecosystem. Collaboration truly drives innovation, and the WEF has been pivotal in exploring new perspectives to make healthcare safer, more accessible, and efficient. By committing to this pledge, we’re contributing to a future where access to healthcare is a reality for all. Let’s continue pushing forward towards a more equitable future! 🌟 #Caresyntax #HealthEquity #SustainableDevelopment #HealthcareInnovation

36

2 Comments

A little late, even though this process started in July.... Excited to share our latest investment in Heads Together Health!! We met Steve DeVrieze in October last year, and we think they are poised for impressive growth! Read more here: https://lnkd.in/ecYcqqkn #earlystagestartup #earlystageinvesting #VCinvestment #ncstartups #nctechstartups

22

This week Mikal Ventures brings you a 2-week breakdown of the US capital market with an emphasis on the Mikal verticals. Over the 2-week period ending May 13, 450 new companies were added, with just under 95,000 companies included in the US Health Tech, Med Tech, Fin Tech, AI Tech, and Ed Tech verticals. AI Tech again saw the greatest percentage of growth in new companies and transactions, weighing in at over double the vertical averages for the period. The US Med Tech vertical led the way in SEC Filings, with Fin Tech leading in news articles. Mikal Ventures publishes these stats to provide a perspective on how the verticals and new startups move through time. We hope you find them informative and thought-provoking. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark https://mikalventures.com/ for additional insights and information.

4

1 Comment

"Digital health is no longer the future; it is the present, reshaping our healthcare landscape in real-time." Excited to be part of the UCSF Digital Health Hub Foundation's Quarterfinalist Party! As a past board member, I'm honored to celebrate the outstanding quarterfinalists. As we reflect on the state of digital health in 2024, it's evident that the COVID-19 pandemic has fundamentally transformed healthcare delivery. The rapid adoption of telemedicine during the crisis has become a permanent fixture, with over 60% of physicians continuing to utilize this technology. The sprint towards smarter healthcare, catalyzed by necessity, has shattered preconceptions about digital-first health experiences. Virtual care is no longer a stopgap but an integral part of a seamless, anytime, anywhere health ecosystem. 🌍 We're witnessing the rise of B2B2C models in remote consultations, with companies like Teladoc Health and Amwell partnering with insurance providers to integrate their services into health plans. Public sector collaborations, like eConsult Health 's partnership with the NHS in the #UK, underscore the potential for remote consultations to enhance efficiency and accessibility at a national level. The digital health landscape is evolving rapidly, with advancements in remote consultations, mental health support, at-home diagnostics, and patient monitoring. AI and generative AI transform care delivery, making it more efficient, personalized, and patient-centric. 🤖 Yet, challenges remain. While venture capital funding for digital health has stabilized after the pandemic boom, it remains below its 2021 peak. Sectors like digital therapeutics face reimbursement hurdles, and we've seen major players like Walmart and Optum close telehealth businesses. Looking ahead, we anticipate further consolidation in digital health, driven by acquisitions to create broader ecosystems encompass telemedicine, mental health, and other specialized services. As healthcare leaders, we must leverage these digital advancements to improve access, enhance patient outcomes, and drive efficiency in our healthcare systems. The future of healthcare is digital, and the time to embrace this transformation is now. Congratulations to all the finalists! 🎉 Looking forward to the grand finale at #HLTH2024 in #LasVegas! 🙌 By the way, the pink drink that we were holding was delicious—and nonalcoholic! The Digital Health Hub Foundation - Digital Health Awards #HealthcareInnovation #DigitalHealth #UCSFHealthHub #Networking #HealthTech #Entrepreneurship #LasVegasFinale Walter Greenleaf, PhD Daniel Kraft, MD Unity Stoakes StartUp Health University of California, San Francisco UCSF Innovation Ventures American Association for Precision Medicine (AAPM) WISE World Investors & Entrepreneurs Society #AAPMhealth #aapm_health

94

7 Comments

Join us tomorrow for a panel discussion on the complex relationship many FirstGens have to money and how that affects founders, investors, operators and others. See you tomorrow! https://lu.ma/9rixyzgs

24

2 Comments

The healthcare landscape is rapidly evolving, driven by advancements in technology and a deeper understanding of patient care. I had the pleasure of speaking with Ambar Bhattacharyya, Co-Managing Partner at Maverick Ventures, on the latest episode of The Full Ratchet. Ambar has partnered with numerous billion-dollar companies like hims & hers, Cityblock Health, Devoted Health, and ConcertAI. His unique journey from rural America to becoming a prominent figure in venture capital offers invaluable insights into the future of healthcare and technology. We discuss his investment strategy at Maverick Ventures, the megatrends shaping healthcare, the impact of AI on the industry, and the importance of integrated care. Ambar also shares his thoughts on the challenges and opportunities in healthcare investment, offering a comprehensive view of what lies ahead. Check out TFR Episode 438 to catch our conversation. You'll be glad you listened. Link to the full episode is in the comment section below.

117

8 Comments

Blended care, combining digital and in-person therapies, is transforming mental health interventions. Patients benefit from seamless channel switching between digital and face-to-face sessions, creating a more integrated service. When we integrate data-driven and digital tools into this model, we gain an even deeper understanding of the patient, leading to more personalised and effective care. Embracing digital integration and data insights is key to enhancing mental health outcomes.  

16

4 Comments

Thank you Henry Peck and Scott Pantel for this great piece by Henry on how common practices in venture apply to digital health investing. In VC we say it's all about the founders, but honestly in healthcare, a great team is critical but is only one ingredient in the recipe to success. Choosing markets vs founders is not necessary. As investors looking for outliers, we must prioritize both. It is the best markets where you can build an amazing company. It is the best founders who can find a wedge and the next business opportunity and identify where and when to grow and how to shorten sales cycles and tap into buyers' priorities. In between these two factors, in digital health, we also have regulation, reimbursement, compliance, IP and all these other fun stuff that may change time to market but will be cracked by the best teams in great markets. Enjoy the read! https://lnkd.in/d6euMfeB

25

1 Comment

This week Mikal Ventures brings you a 4-week breakdown of the US capital market with an emphasis on the Mikal verticals. Over the 4-week period ending April 15, just over 900 new companies were added, with 94,109 companies included in the US Health Tech, Med Tech, Fin Tech, AI Tech, and Ed Tech verticals. AI Tech again saw the greatest percentage of growth in new companies and transactions, weighing in at over double the vertical averages for the period. The US Fin Tech vertical again led the way in SEC Filings and news articles. Mikal Ventures publishes these stats on a rolling 4-week basis to provide a perspective on how the verticals and new startups move through time. We hope you find them informative and thought-provoking. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark https://mikalventures.com/ for additional insights and information.

3

3 Comments

Today's post is about our commitment at Bread and Butter Ventures to investing in women's health within our healthcare vertical, which is a big focus of our fund. Our mission in healthtech broadly is to invest in technology that democratizes access to quality care for all. A report this year from Deloitte shared that investment in women’s health rose by 5% between 2022 and 2023 - heading in the right direction, however, women's health represented just 2% of the $41.2 billion in venture funding that went to health companies in 2023, according to Deloitte’s analysis. There is such tremendous opportunity to innovate and invest for half the world's population. This an economic imperative. Spotlighting today 5 outstanding healthcare startups innovation in women's health who are very proud to have in our portfolio: ⭐ Gabbi: is building a comprehensive breast cancer risk assessment and early detection platform, combining cutting-edge technology with personalized care. As a woman's virtual breast specialist, Gabbi ensures every woman knows her risk and has access to early detection via telehealth. https://www.gabbi.com/. Shoutout Kaitlin Christine ⭐ Chiyo: is a personalized & integrative food-as-medicine platform that helps the next generation of mothers looking for guidance as they navigate the acute transitions of fertility, pregnancy and post-partum. https://wearechiyo.com/. Shoutout Irene Liu ⭐ Delfina: is creating an AI-powered pregnancy care platform to solve the global maternal health crisis. Delfina lowers rates of adverse outcomes, hospitalizations, and NICU stays to deliver substantial savings for health plans and risk-sharing providers. https://www.delfina.com/. Shoutout Senan Ebrahim, MD, PhD Priyanka Vaidya Ali Ebrahim ⭐ Nest Collaborative is the first to create a nationwide network of lactation consultants, available to mom 24/7 through virtual consultations. We were also the first to offer mom a no-cost, insurance-paid experience - which means when she has a problem we can connect her with a consultant within hours and we take care of all the payment and paperwork on the back end. We are, in all ways, her BFF - Breast Feeding Friend. https://lnkd.in/gKCVYvtF. Shoutout Judith Nowlin ⭐ Myya: provides breast cancer survivors completely customizable, fully insurance billable post-mastectomy prosthetics with a state-of-the-art fitting experience online and in-person. https://myya.com/ Jasmine Jones #womenshealth #digitalhealth #venturecapital #startups

92

4 Comments

🚀 𝐔𝐧𝐥𝐨𝐜𝐤 𝐒𝐭𝐚𝐫𝐭𝐮𝐩 𝐒𝐮𝐜𝐜𝐞𝐬𝐬 𝐰𝐢𝐭𝐡 𝐔𝐫𝐢 𝐋𝐞𝐯𝐢𝐧𝐞’𝐬 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬! 🚀 Uri Levine, co-founder of Waze and Moovit, shares invaluable lessons in his book “𝘍𝘢𝘭𝘭 𝘪𝘯 𝘓𝘰𝘷𝘦 𝘸𝘪𝘵𝘩 𝘵𝘩𝘦 𝘗𝘳𝘰𝘣𝘭𝘦𝘮, 𝘕𝘰𝘵 𝘵𝘩𝘦 𝘚𝘰𝘭𝘶𝘵𝘪𝘰𝘯.” Key takeaways include the importance of passionately embracing the problem you’re solving, the necessity of customer retention as a marker of product-market fit, and the strategic use of pitch deck slides. He also emphasises the significance of hiring and firing correctly and observing user behaviour to refine your product. These principles can transform your startup journey, ensuring resilience and growth. 🌟 #StartupSuccess #Entrepreneurship #ProductMarketFit #Innovation

5

Hot off the pre-print server – an important publication authored by the Atropos Health team exploring the performance of LLMs in answering real-world clinical questions. LLMs excel at summarizing and contextualizing existing literature, but cannot generate de novo medical evidence today. The results of the study highlight performance gains attributable to injecting novel, relevant, and up-to-date medical evidence into LLM-powered clinical decision support systems. Brigham Hyde Nigam Shah Saurabh Gombar Read the study here: https://lnkd.in/ecuU25Pq

49

2 Comments

You'd be shocked to know the extent of obesity's economic impact on the US economy -- and how the wider health-tech industry has both a responsibility and an opportunity. 🚨 From 2017–March 2020, the prevalence of obesity and severe obesity among adults aged 20+ was 42% and 9% respectively. Upon doing the math, we find more than 100M adults are obese (22M of whom are severely so)! The same data set suggests obesity rates of 20% in adolescents and children — another 15M individuals. Obesity is linked to 30%-53% of new diabetes cases annually according to the Journal of the American Heart Association. Medical costs for people with obesity tend to be 30% - 40% higher than for those without. In 2019, the economic impact of being overweight and obese was estimated to be $706B, equivalent to $2145 per capita and 3.3% of GDP. Imagine the scope (& responsibility) for health-tech startups. Sure, fitness bands and apps for monitoring, nutrition, and workouts already exist. But what about new ways to incentivize people to exercise & maintain a fitness routine? Apps like Sweatcoin have started this, but what will be the next big leap in making the country and the world a healthier place?

14

3 Comments

This week Mikal Ventures brings you a 4-week breakdown of the US capital market with an emphasis on the Mikal verticals. Over the 4-week period ending November 11, just under 725 new companies were added, resulting in 100,716 companies included in the US Health Tech, Med Tech, Fin Tech, AI Tech, and Ed Tech verticals. Although we are seeing a slowdown in overall activity, US AI Tech again saw the greatest percentage growth in new companies at 16%, vs. the vertical average of 7% for the period. AI Tech also led the group in news articles. US Fin Tech led in transactions, while US Med Tech led in SEC Filings. Mikal Ventures publishes these stats on a rolling 4-week basis to provide a perspective on how the verticals and new startups move through time. We hope you find them informative and thought-provoking. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark https://mikalventures.com/ for additional insights and information.

9

I had the privilege to sit down with William Carbone, who you may already know from his work as CEO and co-founder of Evalify (under Nobody Studios), as well as his role at The Adjacent Possible. For the last 14+ years, William has been a significant innovator in the technology and entrepreneurship space. He has also been a substantial contributor to AI, Aerospace, and Quantum Computing back at IBM. William has been honored with two Stevie Awards for his contributions to business technology and sales/customer service, and recognized in competitions like ESA Nordic Launch 2022, Kiuas Accelerator 2021, and Peter Drucker Forum Challenge finalist. He holds a leadership role at the Rome Business School as a Program Director for the Master in AI, and currently lives a globetrotting lifestyle, shaping innovation ecosystems worldwide. In his downtime he plays piano (he's a self-taught concert pianist), music fuels his creativity and complements his professional endeavours. Evalify is an AI-driven platform designed to assist startups, investors, and legal professionals in assessing intellectual property (IP) risks. The platform analyzes nearly 200 million global patent documents across over 170 jurisdictions to provide a "Freedom-to-Operate" (FTO) score. This score helps users identify potential patent infringements and other IP-related risks quickly, often within minutes, by simply uploading a pitch deck or a product brief. The platform is particularly valuable for early-stage startups, venture capitalists, and legal departments, as it allows them to evaluate the originality of a startup idea, assess competitors, and identify potential legal challenges without the need for traditional, time-consuming, and costly IP analysis. Evalify's AI-powered analysis is designed to be fast, scalable, and cost-effective, making it accessible even for startups that may not have large budgets for extensive legal services​ at their early stage. In a recent collab, Evalify shared their comprehensive reports with some of the members of PTH Venture Studio, and it was highly appreciated by the founders! Mushtaq Ansari Jeremy Barr Maria Pienaar Zeeshan Shahid Zeeshan Shamsi Tahir Ahmed Joshua T. Russell Taylor Khalid Boulhala Ahsan Tariq A.R. Nasir Qureshi Yawar Abbas Charletta Jean-Louis #Evalify #startups #startsuccess #IP #IntellectualProperty #intellectualpropertyrights #DDOA

32

11 Comments

After $400M of capital invested and 30 portfolio companies in health and pharma tech, we are excited to publish our SignalFire health and pharma tech sector thesis, 2024 edition and beyond! 👊 Here are 5 major trends that we're focused on 📈 If you are a founder building in any of these categories below, we'd love to hear from you! 1) Explosion of healthcare data creates both opportunities & risks in the GPT-4 era 2) PharmaTech is accelerating R&D, manufacturing & distribution to tackle inefficiencies 3) The labor shortage crisis and the need for AI to improve productivity 4) Aging population and the shift to hybrid, value-based care models in patients’ homes  5) Scaling access to lifesaving therapeutic breakthroughs: GLP-1s & CGTs Grateful to work closely with an incredible team focused on this sector including our legendary Eric Larsen, and partners in crime Sooah Cho, Tony Pezzullo, Sahir Raoof, Adele English 🙏 What gets me up every morning is our incredible portfolio, each of which making their own dent in our healthcare system for the better — Grow Therapy, Color, Ro, CodaMetrix, Health Gorilla, Verse, Wellth, PayZen, Recora, all.health, Bicycle Health, Form Health, Health Note, Osso VR, Praia Health, Freshpaint, Auxilius, Ovation, OrthoFX, Moxie and many others coming out of stealth soon 🚀 #healthtech #pharmatech #sectorthesis #innovation https://lnkd.in/gDE3nQqK

329

37 Comments

This week Mikal Ventures brings you a 4-week breakdown of the non-US capital market with an emphasis on the Mikal verticals. The 4-week period ending November 25 saw just over 1,300 new companies added, bringing the total to 112,141 companies included in the non-US Health Tech, Med Tech, AI Tech Fin Tech and Ed Tech verticals. Non-US AI Tech again saw the greatest percentage growth in new companies at 16%, vs. the vertical average of 12% for the period. Non-US HeathTech led the group in transactions. Non-US Med Tech led in SEC Filings and news articles.   Mikal Ventures publishes these stats on a rolling 4-week basis to provide a perspective on how the verticals and new startups move through time. We hope you find them informative and thought-provoking. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark https://mikalventures.com/ for additional insights and information.

9

2 Comments

According to Scott Kupor of Andreessen Horowitz: 📉 The “Generalist Model” is Dead 📉 The venture capital landscape is evolving rapidly. The days of generalist investment approaches are giving way to more specialized strategies. Today, founders have the power to choose their investors, not the other way around. We at Nina Capital couldn't agree more. In a world where niche expertise and deep market knowledge are critical, specialized funds are uniquely positioned to add tangible value to the companies they back. As entrepreneurs prioritize VCs who understand their space, generalist investors may find it harder to compete. For investors, this shift underscores the importance of focusing on areas where they can truly deliver insight, resources, and support tailored to specific markets. #VentureCapital #Investment #Specialization #Entrepreneurship #VCTrends #AndreessenHorowitz at SuperVenture in NY

60

4 Comments